Sign inGet started

Leaman John Harold

Insider CIK 1586657 · TRAW Director · MDGN Chief Financial Officer · IMPL Chief Financial Officer · SELB CFO, Treas. & Hd Corp Strategy

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TRAW Traws Pharma, Inc. A Award deriv2026-07-092026-07-1414,150— $014,150SEC↗
TRAW Traws Pharma, Inc. A Award deriv2026-03-082026-03-1033,435— $033,435SEC↗
TRAW Traws Pharma, Inc. A Award deriv2025-12-122025-12-1616,234— $016,234SEC↗
TRAW Traws Pharma, Inc. A Award2025-12-122025-12-164,058— $04,058SEC↗
TRAW Traws Pharma, Inc. A Award deriv2025-11-212025-11-2512,770— $012,770SEC↗
TRAW Traws Pharma, Inc. A Award deriv2025-10-012025-10-1415,609— $015,609SEC↗
IMPL IMPEL PHARMACEUTICALS INC A Award deriv2023-02-142023-02-1670,000— $070,000SEC↗
IMPL IMPEL PHARMACEUTICALS INC M Exercise deriv2022-12-312023-01-0410,571— $00SEC↗
IMPL IMPEL PHARMACEUTICALS INC F Tax w/h2022-12-312023-01-043,627$3.75 $13.6K6,944SEC↗
IMPL IMPEL PHARMACEUTICALS INC M Exercise2022-12-312023-01-0410,571— $010,571SEC↗
IMPL IMPEL NEUROPHARMA INC A Award deriv2022-01-262022-01-28100,000— $0100,000SEC↗
IMPL IMPEL NEUROPHARMA INC A Award deriv2021-10-192021-10-2110,571— $010,571SEC↗
IMPL IMPEL NEUROPHARMA INC A Award deriv2021-07-202021-07-2650,000— $050,000SEC↗
SELB SELECTA BIOSCIENCES INC A Award deriv2018-06-152018-06-1950,000— $050,000SEC↗
SELB SELECTA BIOSCIENCES INC A Award deriv2017-11-172017-11-20220,000— $0220,000SEC↗
MDGN MEDGENICS, INC. A Award deriv2015-02-182015-02-20140,000— $0140,000SEC↗
MDGN MEDGENICS, INC. A Award deriv2014-04-162014-04-1810,314$5.37 $55.4K10,314SEC↗
MDGN MEDGENICS, INC. A Award deriv2013-09-132013-09-17800,000— $0800,000SEC↗